The Current Ratio as of December 2025 (TTM) for Diamyd Medical AB (publ) (DMYD-B.ST) is 10.64

According to Diamyd Medical AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 10.64. This represents a change of 25.11% compared to the average of 8.50 of the last 4 quarters.

Diamyd Medical AB (publ) (DMYD-B.ST) Historical Current Ratio (quarterly & annually)

How has DMYD-B.ST Current Ratio performed in the past?

The mean historical Current Ratio of Diamyd Medical AB (publ) over the last ten years is 7.48. The current 10.64 Current Ratio has changed 14.13% with respect to the historical average. Over the past ten years (40 quarters), DMYD-B.ST's Current Ratio was at its highest in in the February 2021 quarter at 16.48. The Current Ratio was at its lowest in in the May 2017 quarter at 1.53.

Diamyd Medical AB (publ) (DMYD-B.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Diamyd Medical AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Diamyd Medical AB (publ) (DMYD-B.ST) Average Current Ratio

How has DMYD-B.ST Current Ratio performed in the past?

The current Current Ratio of Diamyd Medical AB (publ) (DMYD-B.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Diamyd Medical AB (publ) (DMYD-B.ST) Current Ratio vs. Peers

How is DMYD-B.ST’s Current Ratio compared to its peers?

Diamyd Medical AB (publ)’s Current Ratio is greater than Oncopeptides AB (publ) (3.42), greater than SynAct Pharma AB (3.28), less than Genovis AB (publ.) (10.78), greater than BICO Group AB (publ) (1.06), greater than Cantargia AB (publ) (5.82), greater than Xspray Pharma AB (publ) (6.72), greater than OssDsign AB (publ) (10.37), greater than Infant Bacterial Therapeutics AB (publ) (3.15), greater than Egetis Therapeutics AB (publ) (0.80), greater than BioInvent International AB (publ) (7.40),

Build a custom stock screener for Diamyd Medical AB (publ) (DMYD-B.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diamyd Medical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diamyd Medical AB (publ) (DMYD-B.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diamyd Medical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.